Showing results (11-20 of 172) with videos related to
Sort By:
Pageof 18
Anti-Cancer Agents in Medicinal Chemistry|May 11, 2011
Alteration of ceramide 1-O-functionalization as a promising approach for cancer therapyStephanie Ballereau, Thierry Levade, Yves Genisson, et al.Orphanet Journal of Rare Diseases|May 26, 2025
Advanced strategies for detecting acid sphingomyelinase deficiency type B with attenuated phenotypesThomas Villeneuve, Thibaut Jamme, Robin Schwob, et al.Chembiochem : a European Journal of Chemical Biology|March 17, 2007
Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidasesCarmen Bedia, Josefina Casas, Virginie Garcia, et al.Autophagy|April 2, 2009
Ceramide-induced autophagy: to junk or to protect cells?Sophie Pattingre, Chantal Bauvy, Thierry Levade, et al.Journal of Clinical Medicine|November 13, 2021
Prevalence of Cancer in Acid Sphingomyelinase DeficiencyWladimir Mauhin, Thierry Levade, Marie T Vanier, et al.Frontiers in Cardiovascular Medicine|December 24, 2024
Cerebrotendinous xanthomatosis: a literature review and case studyAnthony Matta, Fabienne Ory Magne, Thierry Levade, et al.Orphanet Journal of Rare Diseases|July 22, 2018
Acid ceramidase deficiency: Farber disease and SMA-PMEFabian P S Yu, Samuel Amintas, Thierry Levade, et al.Biochimica Et Biophysica Acta|January 18, 2006
Lysosomes and lysosomal proteins in cancer cell death (new players of an old struggle)Claudine Tardy, Patrice Codogno, Hélène Autefage, et al.International Journal of Molecular Sciences|September 4, 2012
The tricyclodecan-9-yl-xanthogenate D609 triggers ceramide increase and enhances FasL-induced caspase-dependent and -independent cell death in T lymphocytesDelphine Milhas, Nathalie Andrieu-Abadie, Thierry Levade, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 26, 2019
Inherited monogenic defects of ceramide metabolism: Molecular bases and diagnosesPatricia Dubot, Frédérique Sabourdy, Jitka Rybova, et al.Pageof 18